Ropes & Gray Team Secures Dismissal of False Claims Act Suit with Prejudice for Pharmaceutical Client
U.S. District Judge Nathaniel M. Gorton found that the suit didn’t identify a “single false claim for reimbursement actually presented . . . upon an identified, purportedly off-label use,” and that the remaining allegations were “insufficient to strengthen the inference that a false claim was actually submitted ‘beyond possibility.’”
The Ropes & Gray team included business & securities litigation partner Doug Hallward-Driemeier and life sciences partner Al Cacozza.